Gufic Biosciences Limited (BOM:509079)
India
· Delayed Price · Currency is INR 360.95
+15.20 (4.40%)
At close: Apr 23, 2025
Gufic Biosciences Revenue
Gufic Biosciences had revenue of 2.08B INR in the quarter ending December 31, 2024, with 2.98% growth. This brings the company's revenue in the last twelve months to 8.10B, up 3.19% year-over-year. In the fiscal year ending March 31, 2024, Gufic Biosciences had annual revenue of 8.07B with 16.80% growth.
Revenue (ttm)
8.10B
Revenue Growth
+3.19%
P/S Ratio
4.47
Revenue / Employee
5.43M
Employees
1,491
Market Cap
36.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 8.07B | 1.16B | 16.80% |
| Mar 31, 2023 | 6.91B | -885.35M | -11.36% |
| Mar 31, 2022 | 7.79B | 2.91B | 59.76% |
| Mar 31, 2021 | 4.88B | 1.09B | 28.74% |
| Mar 31, 2020 | 3.79B | 280.68M | 8.00% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,398.38B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,627.08B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,409.52B |
| Infosys | 1,647.16B |
| Bajaj Finance | 358.05B |
Gufic Biosciences News
- 2 months ago - Gufic Biosciences Ltd (BOM:509079) Q3 2025 Earnings Call Highlights: Navigating Profitability ... - GuruFocus
- 2 months ago - Q3 2025 Gufic Biosciences Ltd Earnings Call Transcript - GuruFocus